Theriva Biologics Inc. (NYSE American: TOVX) announced that the U.S. Food and Drug Administration provided general agreement with the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE